Although we believe the sources are reliable for these COPD related news pieces , articles, abstracts, reviews and studies, we cannot guarantee the accuracy or validity of the information supplied . Please note that some of the pieces may be newspaper articles or press releases therefore the links may be temporary in nature.

September 3rd, 2010

From Oranienburg to the Rest of the World: Global Market Launch of Daxas (Roflumilast) Kicks Off in Germany

Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease

Six-minute walk test in pulmonary rehabilitation: Do all patients need a practice test?

Cigarettes Won't Help Teens' Depression

August 29th, 2010

COPD in young patients: A pre-specified analysis of the four-year trial of tiotropium (UPLIFT)

A judge blocks federal funding for stem cell research

Prophylactic antibiotic therapy for chronic bronchitis

Study Finds Even a Little Cigarette Smoke Harms Airway

August 22, 2010

Predicting outcomes following hospitalization for acute exacerbations of COPD.

Non-steroidal anti-inflammatory drugs may affect the presentation and course of community-acquired pneumonia.

Resistance arm training in patients with chronic obstructive pulmonary disease: a randomized controlled trial

Statin Reverses Smoke-induced Pulmonary Hypertension and Prevents Emphysema but not Airway Remodeling

Three-year dispensing patterns with long-acting inhaled drugs in COPD: A database analysis

Emphysema presence, severity and distribution has little impact on the clinical presentation of a cohort of patients with mild to moderate COPD

August 15, 2010

UK sees launch of Novartis COPD drug Onbrez Breezhaler, which Scotland clears for NHS use

http://www.thepharmaletter.com/file/97411/uk-sees-launch-of-novartis-copd-drug-onbrez-breezhaler-which-scotland-clears-for-nhs-use.html

Emphysema presence, severity and distribution has little impact on the clinical presentation of a cohort of patients with mild to moderate COPD

Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD

August 8, 2010

Vitamin D deficiency and reduced lung function in connective tissue-associated interstitial lung diseases

Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters

N30 Pharma Announces FDA Approval to Initiate Phase 1 Clinical Trial for First-in-Class Drug

Panic attacks and panic disorder in chronic obstructive pulmonary disease: A cognitive behavioral perspective

Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD

Sniff nasal inspiratory pressure versus IC/TLC ratio as predictors of mortality in COPD

July 31, 2010

Nycomed�s novel anti-inflammatory therapy Daxas� (roflumilast) receives marketing authorisation in the European Union for patients with COPD

Assessment of Exhaled Breath Condensate pH in Exacerbations of Asthma and COPD:

Predictive accuracy of patient reported exacerbation frequency in chronic obstructive pulmonary disease

Effects of waterpipe tobacco smoking on lung function: a systematic review and meta-analysis

July 14 2010

Physiologic limitations during daily life activities in COPD patients

http://www.resmedjournal.com/article/PIIS0954611110000818/abstract?rss=yes

Performance of diagnostic tests to detect respiratory viruses in older adults

Aspirin and non-small cell lung cancer resections: effect on long-term survival

Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitions

Procalcitonin versus C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD

June 27, 2010

Diabetes Seems to Up Risks for Lung Disease Patients

First Working Replacement Lung Created in Lab

Use and utility of a 24-hour Telephone Support Service for �high risk� patients with COPD

Once-daily Bronchodilators for Chronic Obstructive Pulmonary Disease: Indacaterol versus Tiotropium

June 20th, 2010

IV Steroids May Be Overkill in COPD Patients

Patterns of dietary intake and relation to respiratory disease, forced expiratory volume in 1 s, and decline in 5-y forced expiratory volume^1,2,3

Mono- and Combination Therapy of Long-acting Bronchodilators and Inhaled Corticosteroids in Advanced COPD

Airway count and emphysema assessed by chest CT predicts clinical outcome in smokers

An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease

Early treatment linked to better COPD outcomes

Vitamin B6 May Lower Lung Cancer Risk

Perfusion Scintigraphy and Patient Selection for Lung Volume Reduction Surgery

Contrast enhanced CT-scans are not comparable to non-enhanced scans in emphysema quantification

Efficacy and safety of tiotropium Respimat^� SMI in COPD in two 1-year randomized studies

Comparative effectiveness of macrolides and quinolones for patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD)

Relation between physical capacity, nutritional status and systemic inflammation in COPD

Cost-effectiveness of combination fluticasone propionate�salmeterol 250/50 μg versus salmeterol in severe COPD patients

COPD prevalence and the differences between newly and previously diagnosed COPD patients in a spirometry program

Outdoor air pollution is associated with rapid decline of lung function in α-1-antitrypsin deficiency

Researchers Report Treatment Headway Against Lung Cancer

Studies show combo chemotherapy, new drug prolonged lives of some with advanced disease

Interpreting lung function data using 80 percent of predicted and fixed thresholds misclassifies over 20% of patients.

CHAMPIX (varenicline tartrate) - Changes to the Canadian Product Monograph - For the Public

Treatment Effects of Low-Dose Theophylline Combined With an Inhaled Corticosteroid in COPD

Advantages of Endurance Treadmill Walking Compared With Cycling To Assess Bronchodilator Therapy

Mucoactive therapy in COPD

Osteoporosis Not More Likely With an Inhaled Corticosteroid in COPD

May 30th, 2010

β-Blockers May Be Beneficial in Treating COPD

Planning Ahead: The Living Will and Durable Power of Attorney

Early antibiotic treatment for severe COPD symptoms linked with improved outcomes

The Potential Value of Biomarkers in Diagnosis and Staging of COPD and Exacerbations

Impact of panic disorder upon self-management educational goals in chronic obstructive pulmonary disease?

http://crd.sagepub.com/cgi/content/abstract/7/2/83

BODE-Index vs HADO-Score in Chronic Obstructive Pulmonary Disease: Which one to use in general practice?

Posted May 23rd, 2010

Prognosis of COPD patients requiring frequent hospitalization: Role of airway infection

ATS: Doctors, Patients Differ on COPD Concerns

Posted May 16th, 2010

Tolerability and efficacy of inhaled AZD4818, a CCR1 antagonist, in moderate to severe COPD patients

"water-pipe smoke also contains harmful components, such as nicotine, carbon monoxide, and carcinogens, and may contain a greater quantity of tar and heavy metals than cigarette smoke"

http://pediatrics.aappublications.org/cgi/content/abstract/peds.2009-2335v1

Posted May 9, 2010

Heart Attack Risk Doubles After COPD Exacerbation, Study Finds

Outpatient PR reduces hospital re-admittance risk among COPD patients

Dynamic Hyperinflation During Daily Activities

Does COPD Global Initiative for Chronic Obstructive Lung Disease Stage Matter?

Economic implications of comorbid conditions among Medicaid beneficiaries with COPD

Racial discordance in spirometry comparing four commonly used reference equations to the National Health and Nutrition Examination Study III

Modified BODE indexes: Agreement between multidimensional prognostic systems based on oxygen uptake

Melbourne medical breakthrough means pig lungs could be transplanted into humans

Upper viral respiratory infection, biomarkers and chronic obstructive pulmonary disease (COPD) exacerbations

Effect of tiotropium in men and women with COPD: Results of the 4-year UPLIFT� trial

Nycomed�s novel anti-inflammatory therapy Daxas� (roflumilast) recommended for approval in the European Union for patients with COPD

GOLD stage 0 is associated with excess FEV₁ decline in a representative population sample.

Inhaler Costs and Medication Nonadherence Among Seniors with Chronic Pulmonary Disease

PARADOXICAL TROUGH EFFECTS OF �TRIPLE THERAPY� WITH BUDESONIDE/FORMOTEROL AND TIOTROPIUM BROMIDE ON PULMONARY FUNCTION OUTCOMES IN COPD

Sniff nasal inspiratory pressure versus IC/TLC ratio as predictors of mortality in COPD

Relationship of emphysema and airway disease assessed by CT to exercise capacity in COPD

Launch of CanCOLD - MUHC leads pan-Canadian initiative on respiratory disease

SELF-RATED HEALTH PREDICTS ACUTE EXACERBATIONS AND HOSPITALISATIONS IN PATIENTS WITH COPD

Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis

A lifestyle activity intervention in patients with chronic obstructive pulmonary disease

A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD

Health care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPD

Updated Labelling for Antibiotic Avelox (Moxifloxacin) Regarding Rare Risk of Severe Liver Injury

Entest BioMedical Files Patent Application on Chemokine Technology to Increase Efficacy of Tissue-Specific Stem Cell Homing in COPD Treatment

Blocking Protein May Stem COPD

Study in mice could lead to new treatments for smoking-related diseases.

Treatment effects of low dose theophylline combined with an inhaled corticosteroid in COPD

Patient-Clinician Communication: Associations with Important Health Outcomes among Veterans with COPD

Controller medications and their effects on asthma exacerbations temporally associated with upper respiratory infections

Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis

Affective descriptors of the sensation of breathlessness are more highly associated with severity of impairment than physical descriptors in people with chronic obstructive pulmonary disease

CDC�s Advisory Committee on Immunization Practices (ACIP) Recommends Universal Annual Influenza Vaccination

Decreasing cardiac chamber sizes and associated heart dysfunction in COPD �

High BMI is related to higher incidence of asthma, while a fish and fruit diet is related to a lower� Results from a long-term follow-up study of three age groups in Sweden

Physical inactivity in patients with COPD, a controlled multi-center pilot-study

(Please note that this DOES NOT pertain to those using it for the treatment of COPD)

Talecris Biotherapeutics Receives Health Canada Approval for PROLASTIN(R)-C

New, Concentrated Version of PROLASTIN(R) Delivers the Same Amount of Active Protein in Half the Infusion Volume

Pipe And Cigar Smoking Strongly Associated With Decreased Lung Function, COPD

http://www.medicalnewstoday.com/articles/179282.php

Fat-free mass change after nutritional rehabilitation in weight losing COPD: role of insulin, C-reactive protein and tissue hypoxia

Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis

Virus-free technique enables scientists to easily make stem cells pluripotent, moving closer to possible human therapies http://med.stanford.edu/ism/2010/february/ips-fat.html

The clinical utility of long-term humidification therapy in chronic airway disease

On the Horizon: New Treatments for COPD

A Heavy Toll: Canadian Thoracic Society Report Reveals True Cost of Lung Disease

Health Canada approves tadalafil to help patients with serious, life-threatening lung disease

Overweight elderly 'live longer'

Examining the Role of Vitamin D in Asthma and Chronic Obstructive Pulmonary Disease (COPD)

Inhaled Corticosteroids vs Placebo for Preventing COPD ExacerbationsA Systematic Review and Metaregression of Randomized Controlled Trials

Stem cell line approved for continued research

Entest BioMedical Files Grant Application With the National Heart, Lung and Blood Institute for

Changes in management of chronic obstructive pulmonary disease (COPD) in primary care: EMMEPOC study

Moxifloxacin May Be Better for COPD Outpatients According to New Research Published in the International Journal of COPD

Induced sputum concentrations of mucin in patients with asthma and chronic cough

http://chestjournal.chestpubs.org/content/early/2010/01/13/chest.09-0081.abstract?papetoc

COPD is Associated with a Macrophage Scavenger Receptor (MSR1) Gene Sequence Variation

Health Canada approves SYMBICORT� TURBUHALER� for chronic obstructive pulmonary disease - Increasing patients' quality of life and reducing exacerbations

(Note: Please remember that Symbicort was originally developed and "approved" for use for Asthma)

Leading COPD Drug May Raise Chances of Heart Trouble (Study found Atrovent upped risk, while other research found Spiriva might do opposite)

Pearl Therapeutics gets positive results from phase-2a trial in COPD

Bacteria May Cause H1N1 Death Rate Increase

Entest BioMedical Files Grant Application With NHLBI For Development Of Its ENT-576 Laser Device For Treatment Of COPD

Autopsies Reveal Three Patterns of H1N1 Death

CHEST: Uncertainty Surrounds Opioids in Advanced COPD

Antibiotic Therapy in Elderly Patients with Acute Exacerbation of Chronic Bronchitis

Five new lung function genes discovered

Drug makers quicker to embrace settlements to delay low-cost generics Settlements could cost consumers $35 billion over next 10 years

http://www.bizjournals.com/sanfrancisco/stories/2009/12/14/focus1.html?b=1260766800%5E2567781

Novartis receives approval in the European Union for Onbrez� Breezhaler�, a new once-daily bronchodilator for patients with COPD

One Lot of Zaditen Tablets (for Asthma) Recalled Due to Potential Health Risks

Bone Marrow Stromal Cells Attenuate Lung Injury in a Murine Model of Neonatal Chronic Lung Disease

Entest Biomedical Enters into Discussions with Laser Manufacturer to Develop Proprietary Photoceutical Device for COPD Treatment

Bacterial Disease Linked to H1N1 Flu Worries CDC

FDA Panel Finds Tiotropium Safe for COPD Patients

Michigan Institute for Clinical Health & Research (Univ of Michigan) seeking Participants (LOTT Study)

Study Description: The study will evaluate the effectiveness of long-term, 24-hour oxygen therapy in treating people with COPD who have moderately low blood oxygen levels at rest.

Anthroposophic therapy for asthma: A two-year prospective cohort study in routine outpatient settings

Can dead space fraction predict the length of mechanical ventilation in exacerbated COPD patients?

Stem Cells Heal Lungs of Newborn Animals: May Lead to New Treatments for Lungs of Premature Babies

Discovery of New Type of Immune Cells Regulating Inflammation in Chronic Diseases: Th22 Cells as Milestone of Immunological Research

Coping with COPD
St. John's comedian wants to raise awareness about lung disease

Entest BioMedical Files Patent Application for Selective Targeting of Stem Cells to Lung Using Photoceutical Devices

FDA Panel Rejects Cell Culture Flu Vaccine, Wants More Safety Data

Uptake Medical Presents Data from Phase II Clinical Trial for Patients with Heterogeneous Emphysema at 2009 European Respiratory Society (ERS) Meeting in Vienna, Austria

Note to the Reader: This sounds VERY promising! After you read the news release check on the"Our Technology" tab and watch the video.

COPD Canada Patient Network Salutes the Province of Saskatchewan For Being the 1st Province in the Country to Recognize & Designate November 18th as World COPD Day

Roflumilast Improves Lung Function, Reduces Exacerbations in Patients With COPD and Bronchitis: Presented at CHEST

COPD Canada Patient Network Salutes the Province of Saskatchewan For Being the 1st Province in the Country to Recognize & Designate November 18th as World COPD Day

Health care providers from across Saskatchewan coming together to improve care for people living with depression and chronic obstructive pulmonary disease (COPD)

Lung Tissue Generated From Human Embryonic Stem Cell

CHEST: Anemia Prevalent in COPD

MediciNova Announces Initiation of a Phase Ib Clinical Trial for MN-221 in Patients...

CHEST: No Sex Difference Found in COPD Treatment

Update on pulmonary hypertension complicating chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity

Inhaled Corticosteroids May Be Helpful in Steroid-Naive Patients With Moderate to Severe COPD

Statins for Influenza. Why Don't We Know if it Works Yet? (Although this is a science blog, it is quite indepth as it relates to statins)

Free Book by Dr. Tom Petty - (for download) Adventures of an Oxy-Phille

Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat^� Soft Mist^� Inhaler

Sequential comparison of tiotropium to high-dose ipratropium in patients with chronic obstructive pulmonary disease in a practice setting

Important information about risk of dosing error for TAMIFLU^� (oseltamivir phosphate) Powder for Oral Suspension (12 mg/mL). (Health Canada)

Bio-Matrix Scientific Group, Inc. to Aggressively Pursue Private and Public Grants to Fund Research for Development of Stem Cell Treatment of Chronic Obstructive Pulmonary Disease (COPD)

World's first fatty tissue stem cell transplant into lung of pulmonary fibrosis patient carried out in Alexandroupolis

Face Masks for Patients May Leak, Spread Germs

Canada on Track to Deliver Safe and Effective H1N1 Influenza Vaccine to Canadians

Triple Therapy Reduces COPD Exacerbations

The immediate effect of individual manipulation techniques on pulmonary function measures in persons with chronic obstructive pulmonary disease.

Interaction in COPD experiment (ICE): A hazardous combination of cigarette smoking and bronchodilation in chronic obstructive pulmonary disease.

Chronic Obstructive Pulmonary Disease and Altered Risk of Lung Cancer in a Population-Based Case-Control Study

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial

Surgical masks and N95 respirators provide similar protection against influenza

Novartis bronchodilator QAB149 recommended for approval in European Union to treat patients with chronic obstructive pulmonary disease

Novartis A(H1N1) Pandemic Influenza vaccine Focetria� receives positive opinion from CHMP

Swine Flu Update: Vaccine Approvals, Drug Strategy

Non-invasive ventilation after extubation in hypercapnic patients with chronic respiratory disorders: randomised controlled trial

Aclidinium Bromide via Multidose Dry Powder Inhaler Effective, Safe for COPD: Presented at ERS

Indacaterol Improves Day and Nigh Symptoms in Patients With COPD: Presented at ERS

Scientists Identify Gene For Short-circuiting Excess Mucus In Lung Disease, Common Colds

ALTAIR THERAPEUTICS REPORTS SUCCESSFUL PHASE I STUDY OF INHALED AIR645
Data Shows Safety and Tolerability of First-in-Class Dual IL-4/IL-13 Inhibitor
with Pharmacokinetics Supporting Once-Weekly Asthma Treatment

H1N1 may be contagious for longer than seasonal flu
Data also released on efficacy of masks, new antiviral treatments

The (cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in COPD patients: the COPE-II study

Bronchial vascular remodelling in COPD patients and its relationship with inhaled steroid treatment

Budesonide and the risk of pneumonia: a meta-analysis of individual patient data

Noninvasive ventilation speeds recovery from COPD exacerbations

Patient-Reported Dyspnea in COPD Reliability and Association With Stage of Disease

MP-376 (Levofloxacin Solution for Inhalation) Clinical Program for Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD) http://www.mpexpharma.com/mp-376.html

Update on pulmonary hypertension complicating chronic obstructive pulmonary disease

Pharmacists Could Enhance Asthma And COPD Care (UK)

Bio-Matrix Scientific's Research Subsidiary, Entest BioMedical, Inc., Files Stem Cell Therapy Patent Application for Treatment of COPD

Early COPD Treatment Slows Disease

Budesonide Poses No Risk in COPD

Four Studies Published in The Lancet Show Roflumilast (Daxas), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations

New Tool to Predict the Risk of Death in COPD May Help Physicians to Individualize Treatment

COPD Progress and Challenges 2009

Forest Announces Phase IIb Study Results For Oglemilast in Chronic Obstructive Pulmonary Disease

Swine Flu Vaccine Seems Safe in Early Trials

Tiotropium Added to Inhaled Steroids, Long-Acting Beta-Agonists Linked to Lower COPD Mortality

Nycomed and Forest Laboratories to Collaborate on Daxas^� (roflumilast) for COPD

Health Canada Reviewing Possible Association of Asthma Drug Xolair (Omalizumab) with Increased Risk of Cardiovascular Problems

New Research Investigates The Use Of Diet And Supplements In Ex-Smokers With Lung Disease

A Postmortem Analysis of Major Causes of Early Death in Patients Hospitalized With COPD Exacerbation (Abstract)

AstraZeneca And Astellas Enter Agreement for Co-Promotion of Symbicort Turbuhaler in Japan

Gemifloxacin use in the treatment of acute bacterial exacerbation of chronic bronchitis

Why you're never too old to get asthma

http://www.dailymail.co.uk/health/article-1204059/Why-youre-old-asthma.html

CPAP Intolerance And CPAP Failures Are Common But Somnodent MAS By Somnomed Offers A Comfortable And Effective Treatment For Obstructive Sleep Apnea

Does dietary counselling help outpatients with COPD at risk of malnutrition?

Newly developed sphere helps understand two types of lung cells

Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma

NDA Submitted for Daxas

Nycomed Announces FDA Filing for Daxas in COPD

FDA Checking Heart Risk of Xolair

Home Oxygen Leaders Applaud Introduction Of Medicare Home Oxygen Therapy Act In The U.S. House; Urge Congress To Include Legislation In Health Reform

New technique to repair lungs outside the body may double transplants worldwide

Experts dispute doctor's stem cell breakthrough claim

The gender gap of growing old: Top health risks of aging for men and women (1/3 of the way down the page)

Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease ( Note: You can Download the entire article at the bottom of the page)

Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes

FDA requires Pfizer's smoking cessation drug Chantix, Glaxo's Zyban to carry stronger warning

'I was given a cold to help others'

Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211, A Novel Product Candidate for the Treatment of Respiratory Diseases Results

Living with chronic obstructive pulmonary disease: A survey of patients� knowledge and attitudes

An Increase in the Diagnosed Prevalent Population Will Drive Growth of Nearly $4.3 Billion in the Chronic Obstructive Pulmonary Disease Market

The Immune Response To Influenza Virus Isn't 'All Good'

Chiesi Creates New Research Centre to Study Innovative Therapies for the Treatment of Respiratory and Special Care Diseases

FDA probe of Pfizer's anti-smoking drug continues ( known as Champix in Canada)

Canada to strengthen warning on anti-smoking drug Champix

Canada to strengthen warning on anti-smoking drug Champix - The Globe and Mail

Exacerbation rate, health status and mortality in COPD � a review of potential interventions

Talecris data shows that concentrated form of Prolastin is safe and tolerable; potentially cuts infusion times in half for patients with AAT deficiency (Alpha 1)

Budesonide/formoterol Plus Tiotropium Improves The Quality Of Life Of Patients With Severe COPD

September 3rd, 2010

Cigarettes Won't Help Teens' Depression

August 29th, 2010

COPD in young patients: A pre-specified analysis of the four-year trial of tiotropium (UPLIFT)

A judge blocks federal funding for stem cell research

Prophylactic antibiotic therapy for chronic bronchitis

Study Finds Even a Little Cigarette Smoke Harms Airway

August 22, 2010

Predicting outcomes following hospitalization for acute exacerbations of COPD.

August 15, 2010

August 8, 2010

N30 Pharma Announces FDA Approval to Initiate Phase 1 Clinical Trial for First-in-Class Drug

July 31, 2010

July 14 2010

Physiologic limitations during daily life activities in COPD patients

June 27, 2010

Diabetes Seems to Up Risks for Lung Disease Patients

First Working Replacement Lung Created in Lab

June 20th, 2010

IV Steroids May Be Overkill in COPD Patients

Early treatment linked to better COPD outcomes

Vitamin B6 May Lower Lung Cancer Risk

Researchers Report Treatment Headway Against Lung Cancer

Studies show combo chemotherapy, new drug prolonged lives of some with advanced disease

Mucoactive therapy in COPD

Osteoporosis Not More Likely With an Inhaled Corticosteroid in COPD

May 30th, 2010

β-Blockers May Be Beneficial in Treating COPD

Planning Ahead: The Living Will and Durable Power of Attorney

The Potential Value of Biomarkers in Diagnosis and Staging of COPD and Exacerbations

Impact of panic disorder upon self-management educational goals in chronic obstructive pulmonary disease?

Posted May 23rd, 2010

ATS: Doctors, Patients Differ on COPD Concerns

Posted May 16th, 2010

Posted May 9, 2010

Heart Attack Risk Doubles After COPD Exacerbation, Study Finds

Outpatient PR reduces hospital re-admittance risk among COPD patients

Dynamic Hyperinflation During Daily Activities

Does COPD Global Initiative for Chronic Obstructive Lung Disease Stage Matter?

Lung Reduction Surgery for Severe COPD

Smoking Bans Reduce Secondhand Exposure, MIs

Blocking Protein May Stem COPD

Study in mice could lead to new treatments for smoking-related diseases.

Critical Comparisons of the Clinical Performance of Oxygen Conserving Devices

Talecris Biotherapeutics Receives Health Canada Approval for PROLASTIN(R)-C

New, Concentrated Version of PROLASTIN(R) Delivers the Same Amount of Active Protein in Half the Infusion Volume

Virus-free technique enables scientists to easily make stem cells pluripotent, moving closer to possible human therapies http://med.stanford.edu/ism/2010/february/ips-fat.html

On the Horizon: New Treatments for COPD

Overweight elderly 'live longer'

Inhaled Corticosteroids vs Placebo for Preventing COPD ExacerbationsA Systematic Review and Metaregression of Randomized Controlled Trials

Stem cell line approved for continued research

The Mental Health Consequences of COPD

Induced sputum concentrations of mucin in patients with asthma and chronic cough

Leading COPD Drug May Raise Chances of Heart Trouble (Study found Atrovent upped risk, while other research found Spiriva might do opposite)

Pearl Therapeutics gets positive results from phase-2a trial in COPD

Bacteria May Cause H1N1 Death Rate Increase

Research on Dangers of Sleep Apnea

Emphysema Linked to Secondhand Smoke

Autopsies Reveal Three Patterns of H1N1 Death

CHEST: Uncertainty Surrounds Opioids in Advanced COPD

Antibiotic Therapy in Elderly Patients with Acute Exacerbation of Chronic Bronchitis

Five new lung function genes discovered

Drug makers quicker to embrace settlements to delay low-cost generics Settlements could cost consumers $35 billion over next 10 years

Bacterial Disease Linked to H1N1 Flu Worries CDC

FDA Panel Finds Tiotropium Safe for COPD Patients

FDA Panel Rejects Cell Culture Flu Vaccine, Wants More Safety Data

Lung Tissue Generated From Human Embryonic Stem Cell

CHEST: Anemia Prevalent in COPD

CHEST: No Sex Difference Found in COPD Treatment

Free Book by Dr. Tom Petty - (for download) Adventures of an Oxy-Phille

Bio-Matrix Scientific Group, Inc. to Aggressively Pursue Private and Public Grants to Fund Research for Development of Stem Cell Treatment of Chronic Obstructive Pulmonary Disease (COPD)

Face Masks for Patients May Leak, Spread Germs

Triple Therapy Reduces COPD Exacerbations

Novartis bronchodilator QAB149 recommended for approval in European Union to treat patients with chronic obstructive pulmonary disease

Swine Flu Update: Vaccine Approvals, Drug Strategy

Indacaterol Improves Day and Nigh Symptoms in Patients With COPD: Presented at ERS

Is Fiber Good For Your Lungs?

Noninvasive ventilation speeds recovery from COPD exacerbations

Pharmacists Could Enhance Asthma And COPD Care (UK)

Early COPD Treatment Slows Disease

Nycomed and Forest Laboratories to Collaborate on Daxas^� (roflumilast) for COPD